iSense CGM Overview
- Founded
-
1995
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
iSense CGM General Information
Description
Developer of medical devices for the treatment of diabetes. The company designs and develops minimally-invasive monitoring devices for the treatment of diseases such as diabetes, renal failure, cardiovascular diseases and cancer.
Contact Information
Primary Industry
Monitoring Equipment
Acquirer
Primary Office
- 27700 South West 95th Avenue
- Wilsonville, OR 97070
- United States
+1 (503) 000-0000
iSense CGM Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | Completed | Generating Revenue | ||||
| 1. Angel (individual) | 05-Nov-2014 | 0000 | Completed | Generating Revenue |
iSense CGM Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Susan Petterson | Chief Financial Officer | ||
| David Gillett | Chief Operating Officer |